Category Specific RSS

car-t

Arovella completes development for cell therapy platform, moves to large scale manufacturing

Biotech company Arovella Therapeutics (ASX: ALA), focused on developing its invariant Natural Killer T (iNKT) cell therapy platform for cancer…

1 year ago

FDA grants broad orphan drug status to PTX, shoots share price up almost 30%

Clinical state oncology company Prescient Therapeutics (ASX: PTX) has received the US FDA’s Orphan Drug Designation for its PTX-100 drug,…

2 years ago

Prescient Therapeutics sures supply of cell therapeutic in the hopes of commencing clinical trials

During the second World War, scientists noted that soldiers exposed to nitrogen mustard gas developed interesting hematologic pathology with significantly…

3 years ago

There are no scorpions involved in this company’s latest cancer drug

Most company announcements include a one paragraph summary of the business conveniently located at the bottom of the page. Chimeric…

3 years ago